At FutureLink Barcelona 2019 in June, the serialization discussion will focus on the value of digital information sharing Can healthcare manufacturers...
GOOD DISTRIBUTION PRACTICES
Regulatory issues, such as which pathway to choose, and treatment advances, add to the complexity of combination products.
The integrity of a drug can be compromised in an instant, making the last part of the delivery arguably the most important.
With jumps in e-commerce volume and complexity, manufacturers must address challenges in shipping, communicating with third-party retailers, and secon...
CBER offers information on how to handle temperature-sensitive biologics in power outages or floods.
PDA’s Berlin conference sheds light on manufacturing and logistics, serialization, and regulatory pressure for temperature control of warehouses and...
True or false questions about the handling of biologics and drugs in the supply chain.
Part of a $5.4 million grant will go to boosting cold chain and logistic personnel.
Pharma EXPO presenter addresses key architectural and organizational questions that manufacturers need to consider in building serialization programs.